[1]张亦轩,卫家玉,俞 舜,等.瘢痕内注射曲安奈德和A型肉毒毒素治疗增生性瘢痕— 一项随机对照试验[J].中国美容医学,2022,(2):77-81.
　ZHANG Yixuan,WEI Jiayu,YU Shun,et al.Treating Hypertrophic Scars by Injecting Triamcinolone Acetonide and Botulinum Toxin A (BTX-A) into Focus, A Random Contrast Experiment[J].Medical Aesthetics and Beauty,2022,(2):77-81.
点击复制

瘢痕内注射曲安奈德和A型肉毒毒素治疗增生性瘢痕— 一项随机对照试验()
分享到：

《中国美容医学》[ISSN:1008-6445/CN:61-1347/R]

卷:
期数:
2022年2期
页码:
77-81
栏目:
出版日期:
2022-02-10

文章信息/Info

Title:
Treating Hypertrophic Scars by Injecting Triamcinolone Acetonide and Botulinum Toxin A (BTX-A) into Focus, A Random Contrast Experiment
文章编号:
1008-6455（2022）02-0077-05
作者:
张亦轩1; 卫家玉2; 俞 舜3; 王 丹3; 杨敏烈3; 吕国忠1; 3
(1.南京中医药大学研究生院 江苏 南京 210023 ;2.江南大学无锡医学院 江苏 无锡 214122 ;3.江南大学附属医院烧伤整形科 江苏 无锡 214041 )
Author(s):
ZHANG Yixuan1;  WEI Jiayu2;  YU Shun3;  WANG Dan3; YANG Minlie 3; LV Guozhong1; 3
(1.Graduate School,Nanjing University of Chinese Medicine,Nanjing 210023,Jiangsu,China; 2.Wuxi Medical College,Jiangnan University,Wuxi 214122,Jiangsu,China; 3.Department of Burns and Orthopedic Surgery, Affiliated Hospital of Jiangnan University,Wuxi 214041,Jiangsu,China)
关键词:
增生性瘢痕; 瘢痕治疗; 曲安奈德; A型肉毒毒素; 瘢痕量表
Keywords:
hypertrophic scars;  scar treatment;  triamcinolone acetonide;  botulinum toxin A; scar scale
分类号:
R619+.6
文献标志码:
A
摘要:
目的：比较瘢痕内注射A型肉毒毒素和曲安奈德的疗效及副作用。方法：选取2020年6月-2021年1月笔者医院整形美容科就诊的40例增生性瘢痕患者为研究对象，依据随机数字表法将患者分为两组，每组20例。对照组局部注射曲安奈德治疗，观察组局部注射A型肉毒毒素治疗，比较两组患者治疗后满意度和不良反应发生率，采用改良温哥华瘢痕量表(VSS)评估治疗前后增生性瘢痕的变化，采用视觉模拟评分表（VAS）评估治疗前后瘢痕处痛痒觉变化，采用CBS瘢痕检测仪评估治疗前后瘢痕处皮肤特性（瘢痕面积、色素含量、水分含量及油分含量）变化。结果：观察组患者总满意度为80.00%，显著高于对照组的45.00%，组间差异有统计学意义（P＜0.05）；对照组不良反应发生率为20.00%，显著高于观察组的0.00%，组间差异有统计学意义（χ2=4.444,P＜0.05）。治疗后，两组VSS分值及VAS均较治疗前降低，差异均有统计学意义（P＜0.05）。治疗后两组VSS、VAS改善程度比较，差异无统计学意义（P＞0.05）。结论：曲安奈德和A型肉毒毒素注射液治疗增生性瘢痕，其临床疗效未见明显差异，但肉毒毒素治疗不良反应发生率低，副作用少，患者满意度高，安全性更高，可临床推广应用。
Abstract:
Objective To compare the efficacy and side effects of injecting BTX-A and triamcinolone acetonide into focus. Methods Patients with scar tissue who visited the outpatient department of plastic surgery in our hospital from June 2020 to January 2021 were selected. Forty patients were enrolled and randomly divided into two groups according to the random number table method. The 20 cases in the contrast group were treated with local injection of triamcinolone acetonide while the 20 cases in the observation group were treated with local injection of BTX-A. The satisfaction degrees and adverse reaction incidence rates of patients in the two groups after treatment were treated. The modified Vancouver Scar Scale (VSS) was used to evaluate the changes of hypertrophic scars before and after treatment. Visual Analogue Scale (VAS) was used to evaluate the changes of pain and itching sensations in the focus before and after treatment. CBS Scar Detector introduced from Taiwan was used to evaluate the changes of skin characteristics (scar area, pigment content, moisture content and oil content) before and after treatment. Results The total satisfaction degree of patients in the observation group is 80.00%, which is significantly higher than 45.00% of the contract group. The inter-group difference is of statistical significance (P ＜0.05). The adverse reaction incidence rate of the contrast group is 20.00%, which is significantly higher than 0.00% of the observation group. The inter-group difference is of statistical significance (χ2 =4.444, P ＜0.05). After the treatment, VSS scores and VAS scores of both hormone group and BTX group are both lowered those before the treatment, showing the difference of statistical significance (P＜0.05). After the treatment, the VSS and VAS improvement degrees between both groups are insignificant, showing no statistical significance(P＞0.05). It indicates that scars of both groups are improved after treatment, but with insignificant efficacy differences between two groups. CBS Scar Detector shows that the scar areas of patients before and after treatment are obviously reduced and there is no obvious change in skin pigment content, moisture content and oil content. Conclusion In thetwo groups, there is no obvious difference in clinical efficacy of triamcinolone acetonide and BTX-A injections on hypertrophic scars. However, BTX group is featured by lower adverse reaction incidence rate, fewer side effects, higher patient satisfaction degree and higher security, which is more worthy of clinical promotion.

相似文献/References:

[1]陈 方. 咪喹莫特调节Th1、Th2细胞相关趋化因子对兔耳增生性瘢痕创面愈合和瘢痕增生的影响[J].中国美容医学,2018,(03):100.
　CHEN Fang. Effect of Imiquimod Regulating Th1 and Th2 Cell-associated Chemokines on Wound Healing and Scar Proliferation in Rabbits[J].Medical Aesthetics and Beauty,2018,(2):100.
[2]黄显翔,张 伟,叶光荣,等. CO2点阵激光治疗增生性瘢痕的临床疗效及对TGF-β1表达的影响[J].中国美容医学,2018,(08):108.
　HUANG Xian-xiang,ZHANG Wei,YE Guang-rong,et al.Analysis of the Clinical Effects and Influence on Expression of TGF-β1 of CO2 Lattice Laser in the Treatment of Hypertrophic Scar[J].Medical Aesthetics and Beauty,2018,(2):108.
[3]谢 彬. 深度烧伤患者弹力绷带压力治疗对增生性瘢痕恢复情况的影响[J].中国美容医学,2018,(10):62.
　XIE Bin. Effect of Pressure Treatment with Elastic Bandage on Recovery of Hypertrophic Scar in Patients with Deep Burn[J].Medical Aesthetics and Beauty,2018,(2):62.
[4]俞 舜. 微等离子体射频联合曲安奈德超声导入治疗增生性瘢痕疗效分析[J].中国美容医学,2019,(02):63.
　YU Shun. Clinical Study on Microplasma Radiofrequency Combined with Ultrasonic ImportingTriamcinolone Acetonide in the Treatment of Hypertrophic Scar[J].Medical Aesthetics and Beauty,2019,(2):63.
[5]史 敏,李 娜,郭晓波,等.miR-21调控PTEN/PI3K/Akt通路抑制增生性瘢痕形成的机制研究[J].中国美容医学,2019,(03):92.
　SHI Min,LI Na,GUO Xiao-bo,et al. Mechanism of miR-21 Inhibiting Human Hypertrophic Scar Formation by RegulatingPTEN/PI3K/Akt Pathway[J].Medical Aesthetics and Beauty,2019,(2):92.
[6]李 丽,王 林. 正常皮肤与病理性瘢痕组织中HIF-1α和促炎细胞因子水平比较及两者相关性研究[J].中国美容医学,2019,(04):71.
　LI Li,WANG Lin. Levels of HIF-1α and Proinflammatory Cytokines in Normal Skin and PathologicalScar Tissue and Their Correlation[J].Medical Aesthetics and Beauty,2019,(2):71.
[7]史 敏 李 娜 陈 雷 刘兆旺 魏超鹏综述,封兴华审校. 自噬、miRNA与增生性瘢痕的研究进展[J].中国美容医学,2019,(04):160.
　SHI Min,LI Na,CHEN Lei,et al. Advance in Research on Autophagy, miRNA and Hypertrophic Scar[J].Medical Aesthetics and Beauty,2019,(2):160.
[8]吴志贤,李 响,莫自增,等. 异泽兰黄素通过PDGFβ/ERK信号通路抑制增生性瘢痕生长的机制探讨[J].中国美容医学,2019,(07):44.
　WU Zhi-xian,LI Xiang,MO Zi-zeng,et al.Eupatilin Inhibits Hypertrophic Scar Proliferation Via the PDGFβ/ERK Signaling Pathway[J].Medical Aesthetics and Beauty,2019,(2):44.
[9]伍星蓉,周平华,吴志强,等. 皮损内注射曲安奈德联合CO2点阵激光治疗增生性瘢痕[J].中国美容医学,2019,(09):32.
　WU Xing-rong,ZHOU Ping-hua,WU Zhi-qiang,et al. Intradermic Injection Triamcinolone Acetonide Combined with CO2 Dot Array Laserin the Treatment of Hypertrophic Scar[J].Medical Aesthetics and Beauty,2019,(2):32.
[10]李山林,陈小君,杨海微,等. 曲安奈德辅助激光治疗增生性瘢痕的疗效及对TGF-β1的影响[J].中国美容医学,2019,(12):66.
　LI Shan-lin,CHEN Xiao-jun,YANG Hai-wei,et al. Therapeutic Effect and the Effect of TGF-β1 of Patients with Hypertrophic Scar UsingTriamcinolone Acetonide-assisted Laser Therapy[J].Medical Aesthetics and Beauty,2019,(2):66.

更新日期/Last Update: 2022-03-07